Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
Pre-publication versions of this article are available by contacting email@example.com.
|13 Sep 2011||Submitted||Original manuscript|
|27 Jan 2012||Reviewed||Reviewer Report - Rudolf P. Wüthrich|
|8 Feb 2012||Reviewed||Reviewer Report - Andreas Serra|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|4 Apr 2012||Editorially accepted|
|4 Apr 2012||Article published||10.1186/1471-2369-13-17|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.